JAMA Study: Professionally Fitted Hearing Aids Outperform OTC Models, Though OTC Still Benefits Many Users
By
Karl Strom
Sesame, salt, and substance. A flagship bake.
Summary
A randomized clinical trial published in JAMA Otolaryngology-Head & Neck Surgery by researchers from the University of Iowa and Vanderbilt University found that hearing aids fitted by audiologists using best-practice prescription methods delivered better real-world outcomes for people with mild-to-moderate hearing loss compared to simulated over-the-counter (OTC) hearing aid models. However, the study also noted that OTC devices still provided generally positive results for many users, suggesting both options have value depending on individual needs and access to professional care.
Key quotes
· 3 pulledNew research from the University of Iowa and Vanderbilt University finds that best-practice prescription fittings yielded better real-world outcomes than simulated OTC hearing aid models, though OTC may still benefit many users.
A randomized clinical trial published May 15 in JAMA Otolaryngology-Head & Neck Surgery suggests that hearing aid users with mild-to-moderate hearing loss may get better real-world results when devices are fitted by audiologists using best practices
The study also found generally positive outcomes for over-the-counter (OTC) hearing aids.
You might also wanna read
Google's Debug program seeks EPA approval to release 64 million modified mosquitoes in California and Florida
Google's Debug program plans to release up to 64 million genetically modified "good" mosquitoes in California and Florida over two years to
Researchers develop phage-based preventive treatment for newborn meningitis caused by E. coli K1
Researchers from the Biozentrum, University of Basel, and ETH Zurich have developed a novel preventive treatment for newborn meningitis caus
Daily pill daraxonrasib doubles survival for metastatic pancreatic cancer patients with KRAS mutation
A new daily pill called daraxonrasib has been shown to double survival time for metastatic pancreatic cancer patients with a KRAS mutation.
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
